Amanda Derr

Chief Financial Officer at Duke Clinical Research Institute

Amanda Derr has a diverse and extensive work experience spanning over three decades. Amanda currently holds the position of Chief Financial Officer at Duke Clinical Research Institute, starting in January 2024. Prior to that, they served as the Director of Outsourcing & Contracts at United Therapeutics Corporation from January 2023 to January 2024.

From October 2019 to December 2022, Amanda worked at Impact Pharmaceutical Services as the Senior Vice President of Business Operations & CFO. In this role, they were responsible for setting the strategy and targets for corporate growth and diversification. Amanda also played a significant role in the integration activities after the company's acquisition.

Before joining Impact Pharmaceutical Services, Amanda held a leadership position at Rho, Inc. for over a decade. Amanda served as the Vice President of Finance & Internal Services, where they led and executed multi-functional initiatives in finance, accounting, human resources, and more. In addition, they were accountable for financial performance, including revenue recognition, financial statements, and project reporting.

Their earlier experiences include roles as VP of Business Operations and CFO at Lineberry Research Associates, Audit Administrative Manager at Deloitte & Touche, Manager of Project Analysis at InSite Clinical Trials, and Controller at JC Howard Farms and Goldsboro Milling Company. Amanda also served as an Accounting Manager at Continental Grain Company.

Overall, Amanda's work experience demonstrates their expertise in finance, operations, and strategic leadership across various industries, particularly in the clinical research and pharmaceutical services sectors.

Amanda Derr attended Davidson College and Guilford College, where they earned a Bachelor's Degree in Accounting. Amanda also completed their high school education at Westtown School. Additionally, they obtained certifications as a Chartered Global Management Accountant from AICPA in 2012 and as a Certified Public Accountant (CPA) from the North Carolina State Board of CPA Examiners in 1992.

Links

Previous companies

Deloitte logo
United Therapeutics logo

Timeline

  • Chief Financial Officer

    January, 2024 - present